nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—KCNH2—Loratadine—atopic dermatitis	0.103	0.14	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.072	0.0979	CbGbCtD
Ondansetron—CYP3A7—Tacrolimus—atopic dermatitis	0.072	0.0979	CbGbCtD
Ondansetron—CYP3A5—Tacrolimus—atopic dermatitis	0.054	0.0735	CbGbCtD
Ondansetron—CYP3A4—Pimecrolimus—atopic dermatitis	0.0354	0.0482	CbGbCtD
Ondansetron—CYP1A2—Diphenhydramine—atopic dermatitis	0.0294	0.04	CbGbCtD
Ondansetron—CYP3A7—Hydrocortisone—atopic dermatitis	0.0293	0.0399	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0293	0.0399	CbGbCtD
Ondansetron—CYP2C9—Loratadine—atopic dermatitis	0.0265	0.0361	CbGbCtD
Ondansetron—CYP2C9—Diphenhydramine—atopic dermatitis	0.0265	0.0361	CbGbCtD
Ondansetron—CYP2D6—Loratadine—atopic dermatitis	0.0242	0.033	CbGbCtD
Ondansetron—CYP2D6—Diphenhydramine—atopic dermatitis	0.0242	0.033	CbGbCtD
Ondansetron—CYP3A5—Hydrocortisone—atopic dermatitis	0.022	0.0299	CbGbCtD
Ondansetron—CYP3A4—Tacrolimus—atopic dermatitis	0.0211	0.0286	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.0182	0.0248	CbGbCtD
Ondansetron—CYP3A7—Dexamethasone—atopic dermatitis	0.0182	0.0248	CbGbCtD
Ondansetron—CYP2E1—Dexamethasone—atopic dermatitis	0.0176	0.0239	CbGbCtD
Ondansetron—CYP3A4—Loratadine—atopic dermatitis	0.0154	0.021	CbGbCtD
Ondansetron—CYP3A4—Methylprednisolone—atopic dermatitis	0.0141	0.0192	CbGbCtD
Ondansetron—CYP3A5—Dexamethasone—atopic dermatitis	0.0137	0.0186	CbGbCtD
Ondansetron—CYP3A4—Triamcinolone—atopic dermatitis	0.0107	0.0145	CbGbCtD
Ondansetron—CYP2C9—Dexamethasone—atopic dermatitis	0.00917	0.0125	CbGbCtD
Ondansetron—CYP3A4—Betamethasone—atopic dermatitis	0.00916	0.0125	CbGbCtD
Ondansetron—CYP3A4—Prednisolone—atopic dermatitis	0.00904	0.0123	CbGbCtD
Ondansetron—CYP3A4—Hydrocortisone—atopic dermatitis	0.00857	0.0117	CbGbCtD
Ondansetron—CYP3A4—Prednisone—atopic dermatitis	0.00854	0.0116	CbGbCtD
Ondansetron—CYP2D6—Dexamethasone—atopic dermatitis	0.00838	0.0114	CbGbCtD
Ondansetron—CYP3A4—Dexamethasone—atopic dermatitis	0.00533	0.00725	CbGbCtD
Ondansetron—Erythema—Prednisolone—atopic dermatitis	0.000232	0.00106	CcSEcCtD
Ondansetron—Eye disorder—Methylprednisolone—atopic dermatitis	0.000229	0.00105	CcSEcCtD
Ondansetron—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000227	0.00104	CcSEcCtD
Ondansetron—Erythema—Hydrocortisone—atopic dermatitis	0.000227	0.00104	CcSEcCtD
Ondansetron—Bradycardia—Dexamethasone—atopic dermatitis	0.000227	0.00104	CcSEcCtD
Ondansetron—Bradycardia—Betamethasone—atopic dermatitis	0.000227	0.00104	CcSEcCtD
Ondansetron—Haemoglobin—Dexamethasone—atopic dermatitis	0.000224	0.00102	CcSEcCtD
Ondansetron—Haemoglobin—Betamethasone—atopic dermatitis	0.000224	0.00102	CcSEcCtD
Ondansetron—Haemorrhage—Betamethasone—atopic dermatitis	0.000223	0.00102	CcSEcCtD
Ondansetron—Haemorrhage—Dexamethasone—atopic dermatitis	0.000223	0.00102	CcSEcCtD
Ondansetron—Angiopathy—Methylprednisolone—atopic dermatitis	0.000222	0.00102	CcSEcCtD
Ondansetron—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000221	0.00101	CcSEcCtD
Ondansetron—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000221	0.00101	CcSEcCtD
Ondansetron—Arrhythmia—Triamcinolone—atopic dermatitis	0.000219	0.001	CcSEcCtD
Ondansetron—Vision blurred—Prednisolone—atopic dermatitis	0.000219	0.001	CcSEcCtD
Ondansetron—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000219	0.001	CcSEcCtD
Ondansetron—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000219	0.001	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000216	0.000986	CcSEcCtD
Ondansetron—Visual impairment—Betamethasone—atopic dermatitis	0.000215	0.000982	CcSEcCtD
Ondansetron—Visual impairment—Dexamethasone—atopic dermatitis	0.000215	0.000982	CcSEcCtD
Ondansetron—Erythema—Triamcinolone—atopic dermatitis	0.000214	0.000977	CcSEcCtD
Ondansetron—Erythema—Methylprednisolone—atopic dermatitis	0.000213	0.000975	CcSEcCtD
Ondansetron—Asthenia—Tacrolimus—atopic dermatitis	0.000213	0.000974	CcSEcCtD
Ondansetron—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000213	0.000974	CcSEcCtD
Ondansetron—Angioedema—Prednisolone—atopic dermatitis	0.000212	0.000971	CcSEcCtD
Ondansetron—Myocardial infarction—Prednisone—atopic dermatitis	0.000212	0.000969	CcSEcCtD
Ondansetron—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000211	0.000963	CcSEcCtD
Ondansetron—Pruritus—Tacrolimus—atopic dermatitis	0.00021	0.000961	CcSEcCtD
Ondansetron—Malaise—Prednisolone—atopic dermatitis	0.00021	0.000958	CcSEcCtD
Ondansetron—Syncope—Prednisolone—atopic dermatitis	0.000208	0.000953	CcSEcCtD
Ondansetron—Eye disorder—Dexamethasone—atopic dermatitis	0.000208	0.000952	CcSEcCtD
Ondansetron—Eye disorder—Betamethasone—atopic dermatitis	0.000208	0.000952	CcSEcCtD
Ondansetron—Angioedema—Hydrocortisone—atopic dermatitis	0.000207	0.000948	CcSEcCtD
Ondansetron—Malaise—Hydrocortisone—atopic dermatitis	0.000205	0.000936	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisolone—atopic dermatitis	0.000204	0.000934	CcSEcCtD
Ondansetron—Syncope—Hydrocortisone—atopic dermatitis	0.000204	0.000931	CcSEcCtD
Ondansetron—Diarrhoea—Tacrolimus—atopic dermatitis	0.000203	0.000929	CcSEcCtD
Ondansetron—Angiopathy—Dexamethasone—atopic dermatitis	0.000202	0.000924	CcSEcCtD
Ondansetron—Angiopathy—Betamethasone—atopic dermatitis	0.000202	0.000924	CcSEcCtD
Ondansetron—Convulsion—Prednisolone—atopic dermatitis	0.000201	0.000921	CcSEcCtD
Ondansetron—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.0002	0.000912	CcSEcCtD
Ondansetron—Arrhythmia—Dexamethasone—atopic dermatitis	0.000199	0.00091	CcSEcCtD
Ondansetron—Arrhythmia—Betamethasone—atopic dermatitis	0.000199	0.00091	CcSEcCtD
Ondansetron—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000198	0.000907	CcSEcCtD
Ondansetron—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000198	0.000905	CcSEcCtD
Ondansetron—Bradycardia—Prednisone—atopic dermatitis	0.000198	0.000903	CcSEcCtD
Ondansetron—Convulsion—Hydrocortisone—atopic dermatitis	0.000197	0.000899	CcSEcCtD
Ondansetron—Dizziness—Tacrolimus—atopic dermatitis	0.000196	0.000898	CcSEcCtD
Ondansetron—Discomfort—Prednisolone—atopic dermatitis	0.000196	0.000894	CcSEcCtD
Ondansetron—Angioedema—Triamcinolone—atopic dermatitis	0.000195	0.000893	CcSEcCtD
Ondansetron—Haemoglobin—Prednisone—atopic dermatitis	0.000195	0.000892	CcSEcCtD
Ondansetron—Angioedema—Methylprednisolone—atopic dermatitis	0.000195	0.000891	CcSEcCtD
Ondansetron—Haemorrhage—Prednisone—atopic dermatitis	0.000194	0.000887	CcSEcCtD
Ondansetron—Erythema—Betamethasone—atopic dermatitis	0.000194	0.000887	CcSEcCtD
Ondansetron—Erythema—Dexamethasone—atopic dermatitis	0.000194	0.000887	CcSEcCtD
Ondansetron—Malaise—Triamcinolone—atopic dermatitis	0.000193	0.000881	CcSEcCtD
Ondansetron—Anxiety—Hydrocortisone—atopic dermatitis	0.000193	0.000881	CcSEcCtD
Ondansetron—Malaise—Methylprednisolone—atopic dermatitis	0.000192	0.000879	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000192	0.000878	CcSEcCtD
Ondansetron—Syncope—Triamcinolone—atopic dermatitis	0.000192	0.000876	CcSEcCtD
Ondansetron—Syncope—Methylprednisolone—atopic dermatitis	0.000191	0.000874	CcSEcCtD
Ondansetron—Discomfort—Hydrocortisone—atopic dermatitis	0.000191	0.000873	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisolone—atopic dermatitis	0.00019	0.000867	CcSEcCtD
Ondansetron—Vomiting—Tacrolimus—atopic dermatitis	0.000189	0.000863	CcSEcCtD
Ondansetron—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000188	0.000859	CcSEcCtD
Ondansetron—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000187	0.000857	CcSEcCtD
Ondansetron—Rash—Tacrolimus—atopic dermatitis	0.000187	0.000856	CcSEcCtD
Ondansetron—Dermatitis—Tacrolimus—atopic dermatitis	0.000187	0.000855	CcSEcCtD
Ondansetron—Shock—Prednisolone—atopic dermatitis	0.000187	0.000853	CcSEcCtD
Ondansetron—Cough—Triamcinolone—atopic dermatitis	0.000187	0.000853	CcSEcCtD
Ondansetron—Headache—Tacrolimus—atopic dermatitis	0.000186	0.000851	CcSEcCtD
Ondansetron—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000185	0.000847	CcSEcCtD
Ondansetron—Convulsion—Triamcinolone—atopic dermatitis	0.000185	0.000847	CcSEcCtD
Ondansetron—Tachycardia—Prednisolone—atopic dermatitis	0.000185	0.000846	CcSEcCtD
Ondansetron—Convulsion—Methylprednisolone—atopic dermatitis	0.000185	0.000845	CcSEcCtD
Ondansetron—Shock—Hydrocortisone—atopic dermatitis	0.000182	0.000833	CcSEcCtD
Ondansetron—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000182	0.000831	CcSEcCtD
Ondansetron—Eye disorder—Prednisone—atopic dermatitis	0.000181	0.000829	CcSEcCtD
Ondansetron—Anxiety—Methylprednisolone—atopic dermatitis	0.000181	0.000827	CcSEcCtD
Ondansetron—Tachycardia—Hydrocortisone—atopic dermatitis	0.000181	0.000827	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00018	0.000824	CcSEcCtD
Ondansetron—Flushing—Prednisone—atopic dermatitis	0.00018	0.000823	CcSEcCtD
Ondansetron—Skin disorder—Hydrocortisone—atopic dermatitis	0.00018	0.000823	CcSEcCtD
Ondansetron—Ill-defined disorder—Betamethasone—atopic dermatitis	0.00018	0.000823	CcSEcCtD
Ondansetron—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.00018	0.000823	CcSEcCtD
Ondansetron—Discomfort—Triamcinolone—atopic dermatitis	0.00018	0.000822	CcSEcCtD
Ondansetron—Discomfort—Methylprednisolone—atopic dermatitis	0.000179	0.00082	CcSEcCtD
Ondansetron—Dry mouth—Triamcinolone—atopic dermatitis	0.000178	0.000814	CcSEcCtD
Ondansetron—Angioedema—Dexamethasone—atopic dermatitis	0.000177	0.00081	CcSEcCtD
Ondansetron—Angioedema—Betamethasone—atopic dermatitis	0.000177	0.00081	CcSEcCtD
Ondansetron—Angiopathy—Prednisone—atopic dermatitis	0.000176	0.000805	CcSEcCtD
Ondansetron—Immune system disorder—Prednisone—atopic dermatitis	0.000175	0.000801	CcSEcCtD
Ondansetron—Malaise—Dexamethasone—atopic dermatitis	0.000175	0.0008	CcSEcCtD
Ondansetron—Malaise—Betamethasone—atopic dermatitis	0.000175	0.0008	CcSEcCtD
Ondansetron—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000174	0.000798	CcSEcCtD
Ondansetron—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000174	0.000796	CcSEcCtD
Ondansetron—Syncope—Betamethasone—atopic dermatitis	0.000174	0.000795	CcSEcCtD
Ondansetron—Syncope—Dexamethasone—atopic dermatitis	0.000174	0.000795	CcSEcCtD
Ondansetron—Arrhythmia—Prednisone—atopic dermatitis	0.000173	0.000792	CcSEcCtD
Ondansetron—Hypotension—Hydrocortisone—atopic dermatitis	0.000173	0.000792	CcSEcCtD
Ondansetron—Shock—Triamcinolone—atopic dermatitis	0.000172	0.000785	CcSEcCtD
Ondansetron—Shock—Methylprednisolone—atopic dermatitis	0.000171	0.000783	CcSEcCtD
Ondansetron—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000171	0.00078	CcSEcCtD
Ondansetron—Loss of consciousness—Betamethasone—atopic dermatitis	0.00017	0.000779	CcSEcCtD
Ondansetron—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00017	0.000779	CcSEcCtD
Ondansetron—Paraesthesia—Prednisolone—atopic dermatitis	0.00017	0.000779	CcSEcCtD
Ondansetron—Tachycardia—Triamcinolone—atopic dermatitis	0.00017	0.000778	CcSEcCtD
Ondansetron—Tachycardia—Methylprednisolone—atopic dermatitis	0.00017	0.000777	CcSEcCtD
Ondansetron—Skin disorder—Methylprednisolone—atopic dermatitis	0.000169	0.000773	CcSEcCtD
Ondansetron—Erythema—Prednisone—atopic dermatitis	0.000169	0.000772	CcSEcCtD
Ondansetron—Convulsion—Dexamethasone—atopic dermatitis	0.000168	0.000768	CcSEcCtD
Ondansetron—Convulsion—Betamethasone—atopic dermatitis	0.000168	0.000768	CcSEcCtD
Ondansetron—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000166	0.000761	CcSEcCtD
Ondansetron—Anxiety—Dexamethasone—atopic dermatitis	0.000165	0.000752	CcSEcCtD
Ondansetron—Anxiety—Betamethasone—atopic dermatitis	0.000165	0.000752	CcSEcCtD
Ondansetron—Discomfort—Dexamethasone—atopic dermatitis	0.000163	0.000746	CcSEcCtD
Ondansetron—Discomfort—Betamethasone—atopic dermatitis	0.000163	0.000746	CcSEcCtD
Ondansetron—Hypotension—Methylprednisolone—atopic dermatitis	0.000163	0.000744	CcSEcCtD
Ondansetron—Pain—Prednisolone—atopic dermatitis	0.000162	0.000742	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.00016	0.000731	CcSEcCtD
Ondansetron—Fatigue—Hydrocortisone—atopic dermatitis	0.00016	0.00073	CcSEcCtD
Ondansetron—Vision blurred—Prednisone—atopic dermatitis	0.000159	0.000728	CcSEcCtD
Ondansetron—Pain—Hydrocortisone—atopic dermatitis	0.000158	0.000724	CcSEcCtD
Ondansetron—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000158	0.000724	CcSEcCtD
Ondansetron—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000158	0.000724	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisone—atopic dermatitis	0.000157	0.000717	CcSEcCtD
Ondansetron—Paraesthesia—Triamcinolone—atopic dermatitis	0.000157	0.000716	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisolone—atopic dermatitis	0.000156	0.000715	CcSEcCtD
Ondansetron—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000156	0.000715	CcSEcCtD
Ondansetron—Shock—Dexamethasone—atopic dermatitis	0.000156	0.000712	CcSEcCtD
Ondansetron—Shock—Betamethasone—atopic dermatitis	0.000156	0.000712	CcSEcCtD
Ondansetron—Dyspnoea—Triamcinolone—atopic dermatitis	0.000156	0.000711	CcSEcCtD
Ondansetron—Nervous system disorder—Betamethasone—atopic dermatitis	0.000155	0.00071	CcSEcCtD
Ondansetron—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000155	0.00071	CcSEcCtD
Ondansetron—Agitation—Prednisone—atopic dermatitis	0.000155	0.00071	CcSEcCtD
Ondansetron—Tachycardia—Betamethasone—atopic dermatitis	0.000155	0.000706	CcSEcCtD
Ondansetron—Tachycardia—Dexamethasone—atopic dermatitis	0.000155	0.000706	CcSEcCtD
Ondansetron—Angioedema—Prednisone—atopic dermatitis	0.000154	0.000706	CcSEcCtD
Ondansetron—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000153	0.000698	CcSEcCtD
Ondansetron—Malaise—Prednisone—atopic dermatitis	0.000152	0.000696	CcSEcCtD
Ondansetron—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000152	0.000693	CcSEcCtD
Ondansetron—Syncope—Prednisone—atopic dermatitis	0.000151	0.000693	CcSEcCtD
Ondansetron—Urticaria—Prednisolone—atopic dermatitis	0.000151	0.000689	CcSEcCtD
Ondansetron—Fatigue—Triamcinolone—atopic dermatitis	0.00015	0.000688	CcSEcCtD
Ondansetron—Fatigue—Methylprednisolone—atopic dermatitis	0.00015	0.000686	CcSEcCtD
Ondansetron—Pain—Triamcinolone—atopic dermatitis	0.000149	0.000682	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisone—atopic dermatitis	0.000148	0.000679	CcSEcCtD
Ondansetron—Hypotension—Dexamethasone—atopic dermatitis	0.000148	0.000676	CcSEcCtD
Ondansetron—Hypotension—Betamethasone—atopic dermatitis	0.000148	0.000676	CcSEcCtD
Ondansetron—Urticaria—Hydrocortisone—atopic dermatitis	0.000147	0.000673	CcSEcCtD
Ondansetron—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000146	0.00067	CcSEcCtD
Ondansetron—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000146	0.00067	CcSEcCtD
Ondansetron—Convulsion—Prednisone—atopic dermatitis	0.000146	0.000669	CcSEcCtD
Ondansetron—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000144	0.000657	CcSEcCtD
Ondansetron—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000143	0.000656	CcSEcCtD
Ondansetron—Anxiety—Prednisone—atopic dermatitis	0.000143	0.000655	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000143	0.000653	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000142	0.000651	CcSEcCtD
Ondansetron—Paraesthesia—Dexamethasone—atopic dermatitis	0.000142	0.00065	CcSEcCtD
Ondansetron—Paraesthesia—Betamethasone—atopic dermatitis	0.000142	0.00065	CcSEcCtD
Ondansetron—Discomfort—Prednisone—atopic dermatitis	0.000142	0.00065	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisolone—atopic dermatitis	0.00014	0.000639	CcSEcCtD
Ondansetron—Urticaria—Triamcinolone—atopic dermatitis	0.000139	0.000634	CcSEcCtD
Ondansetron—Urticaria—Methylprednisolone—atopic dermatitis	0.000138	0.000632	CcSEcCtD
Ondansetron—Body temperature increased—Triamcinolone—atopic dermatitis	0.000138	0.000631	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisone—atopic dermatitis	0.000138	0.00063	CcSEcCtD
Ondansetron—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000138	0.000629	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000137	0.000625	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000137	0.000625	CcSEcCtD
Ondansetron—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000137	0.000624	CcSEcCtD
Ondansetron—Fatigue—Dexamethasone—atopic dermatitis	0.000136	0.000624	CcSEcCtD
Ondansetron—Fatigue—Betamethasone—atopic dermatitis	0.000136	0.000624	CcSEcCtD
Ondansetron—Shock—Prednisone—atopic dermatitis	0.000136	0.00062	CcSEcCtD
Ondansetron—Pain—Betamethasone—atopic dermatitis	0.000135	0.000619	CcSEcCtD
Ondansetron—Pain—Dexamethasone—atopic dermatitis	0.000135	0.000619	CcSEcCtD
Ondansetron—Nervous system disorder—Prednisone—atopic dermatitis	0.000135	0.000618	CcSEcCtD
Ondansetron—Tachycardia—Prednisone—atopic dermatitis	0.000135	0.000615	CcSEcCtD
Ondansetron—Skin disorder—Prednisone—atopic dermatitis	0.000134	0.000612	CcSEcCtD
Ondansetron—Asthenia—Hydrocortisone—atopic dermatitis	0.000133	0.000608	CcSEcCtD
Ondansetron—Pruritus—Hydrocortisone—atopic dermatitis	0.000131	0.000599	CcSEcCtD
Ondansetron—Feeling abnormal—Dexamethasone—atopic dermatitis	0.00013	0.000596	CcSEcCtD
Ondansetron—Feeling abnormal—Betamethasone—atopic dermatitis	0.00013	0.000596	CcSEcCtD
Ondansetron—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000129	0.000592	CcSEcCtD
Ondansetron—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000129	0.000592	CcSEcCtD
Ondansetron—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000129	0.000588	CcSEcCtD
Ondansetron—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000128	0.000586	CcSEcCtD
Ondansetron—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000127	0.00058	CcSEcCtD
Ondansetron—Urticaria—Betamethasone—atopic dermatitis	0.000126	0.000575	CcSEcCtD
Ondansetron—Urticaria—Dexamethasone—atopic dermatitis	0.000126	0.000575	CcSEcCtD
Ondansetron—Dizziness—Prednisolone—atopic dermatitis	0.000125	0.000574	CcSEcCtD
Ondansetron—Asthenia—Triamcinolone—atopic dermatitis	0.000125	0.000572	CcSEcCtD
Ondansetron—Abdominal pain—Betamethasone—atopic dermatitis	0.000125	0.000572	CcSEcCtD
Ondansetron—Abdominal pain—Dexamethasone—atopic dermatitis	0.000125	0.000572	CcSEcCtD
Ondansetron—Body temperature increased—Dexamethasone—atopic dermatitis	0.000125	0.000572	CcSEcCtD
Ondansetron—Body temperature increased—Betamethasone—atopic dermatitis	0.000125	0.000572	CcSEcCtD
Ondansetron—Asthenia—Methylprednisolone—atopic dermatitis	0.000125	0.000571	CcSEcCtD
Ondansetron—Paraesthesia—Prednisone—atopic dermatitis	0.000124	0.000566	CcSEcCtD
Ondansetron—Pruritus—Triamcinolone—atopic dermatitis	0.000123	0.000564	CcSEcCtD
Ondansetron—Pruritus—Methylprednisolone—atopic dermatitis	0.000123	0.000563	CcSEcCtD
Ondansetron—Dizziness—Hydrocortisone—atopic dermatitis	0.000123	0.00056	CcSEcCtD
Ondansetron—Rash—Prednisolone—atopic dermatitis	0.00012	0.000547	CcSEcCtD
Ondansetron—Dermatitis—Prednisolone—atopic dermatitis	0.00012	0.000546	CcSEcCtD
Ondansetron—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000119	0.000545	CcSEcCtD
Ondansetron—Fatigue—Prednisone—atopic dermatitis	0.000119	0.000543	CcSEcCtD
Ondansetron—Headache—Prednisolone—atopic dermatitis	0.000119	0.000543	CcSEcCtD
Ondansetron—Constipation—Prednisone—atopic dermatitis	0.000118	0.000539	CcSEcCtD
Ondansetron—Vomiting—Hydrocortisone—atopic dermatitis	0.000118	0.000539	CcSEcCtD
Ondansetron—Rash—Hydrocortisone—atopic dermatitis	0.000117	0.000534	CcSEcCtD
Ondansetron—Dermatitis—Hydrocortisone—atopic dermatitis	0.000117	0.000534	CcSEcCtD
Ondansetron—Headache—Hydrocortisone—atopic dermatitis	0.000116	0.000531	CcSEcCtD
Ondansetron—Dizziness—Triamcinolone—atopic dermatitis	0.000115	0.000527	CcSEcCtD
Ondansetron—Dizziness—Methylprednisolone—atopic dermatitis	0.000115	0.000526	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisone—atopic dermatitis	0.000114	0.000519	CcSEcCtD
Ondansetron—Asthenia—Dexamethasone—atopic dermatitis	0.000114	0.000519	CcSEcCtD
Ondansetron—Asthenia—Betamethasone—atopic dermatitis	0.000114	0.000519	CcSEcCtD
Ondansetron—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000113	0.000515	CcSEcCtD
Ondansetron—Pruritus—Dexamethasone—atopic dermatitis	0.000112	0.000512	CcSEcCtD
Ondansetron—Pruritus—Betamethasone—atopic dermatitis	0.000112	0.000512	CcSEcCtD
Ondansetron—Vomiting—Triamcinolone—atopic dermatitis	0.000111	0.000507	CcSEcCtD
Ondansetron—Vomiting—Methylprednisolone—atopic dermatitis	0.000111	0.000506	CcSEcCtD
Ondansetron—Rash—Triamcinolone—atopic dermatitis	0.00011	0.000503	CcSEcCtD
Ondansetron—Dermatitis—Triamcinolone—atopic dermatitis	0.00011	0.000502	CcSEcCtD
Ondansetron—Rash—Methylprednisolone—atopic dermatitis	0.00011	0.000502	CcSEcCtD
Ondansetron—Dermatitis—Methylprednisolone—atopic dermatitis	0.00011	0.000501	CcSEcCtD
Ondansetron—Urticaria—Prednisone—atopic dermatitis	0.00011	0.000501	CcSEcCtD
Ondansetron—Headache—Triamcinolone—atopic dermatitis	0.000109	0.0005	CcSEcCtD
Ondansetron—Headache—Methylprednisolone—atopic dermatitis	0.000109	0.000499	CcSEcCtD
Ondansetron—Body temperature increased—Prednisone—atopic dermatitis	0.000109	0.000498	CcSEcCtD
Ondansetron—Abdominal pain—Prednisone—atopic dermatitis	0.000109	0.000498	CcSEcCtD
Ondansetron—Diarrhoea—Betamethasone—atopic dermatitis	0.000108	0.000495	CcSEcCtD
Ondansetron—Diarrhoea—Dexamethasone—atopic dermatitis	0.000108	0.000495	CcSEcCtD
Ondansetron—Dizziness—Betamethasone—atopic dermatitis	0.000105	0.000479	CcSEcCtD
Ondansetron—Dizziness—Dexamethasone—atopic dermatitis	0.000105	0.000479	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisone—atopic dermatitis	0.000102	0.000464	CcSEcCtD
Ondansetron—Vomiting—Dexamethasone—atopic dermatitis	0.000101	0.00046	CcSEcCtD
Ondansetron—Vomiting—Betamethasone—atopic dermatitis	0.000101	0.00046	CcSEcCtD
Ondansetron—Rash—Dexamethasone—atopic dermatitis	9.98e-05	0.000456	CcSEcCtD
Ondansetron—Rash—Betamethasone—atopic dermatitis	9.98e-05	0.000456	CcSEcCtD
Ondansetron—Dermatitis—Betamethasone—atopic dermatitis	9.97e-05	0.000456	CcSEcCtD
Ondansetron—Dermatitis—Dexamethasone—atopic dermatitis	9.97e-05	0.000456	CcSEcCtD
Ondansetron—Headache—Betamethasone—atopic dermatitis	9.92e-05	0.000453	CcSEcCtD
Ondansetron—Headache—Dexamethasone—atopic dermatitis	9.92e-05	0.000453	CcSEcCtD
Ondansetron—Asthenia—Prednisone—atopic dermatitis	9.89e-05	0.000452	CcSEcCtD
Ondansetron—Pruritus—Prednisone—atopic dermatitis	9.75e-05	0.000446	CcSEcCtD
Ondansetron—Diarrhoea—Prednisone—atopic dermatitis	9.43e-05	0.000431	CcSEcCtD
Ondansetron—Dizziness—Prednisone—atopic dermatitis	9.12e-05	0.000417	CcSEcCtD
Ondansetron—Vomiting—Prednisone—atopic dermatitis	8.77e-05	0.000401	CcSEcCtD
Ondansetron—Rash—Prednisone—atopic dermatitis	8.69e-05	0.000397	CcSEcCtD
Ondansetron—Dermatitis—Prednisone—atopic dermatitis	8.68e-05	0.000397	CcSEcCtD
Ondansetron—Headache—Prednisone—atopic dermatitis	8.64e-05	0.000395	CcSEcCtD
Ondansetron—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	8.16e-05	0.00176	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	8.08e-05	0.00175	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—CXCR3—atopic dermatitis	8.08e-05	0.00175	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCL27—atopic dermatitis	8.05e-05	0.00174	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—CXCL10—atopic dermatitis	8.02e-05	0.00173	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	7.97e-05	0.00172	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	7.82e-05	0.00169	CbGpPWpGaD
Ondansetron—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.76e-05	0.00168	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—STAT6—atopic dermatitis	7.74e-05	0.00167	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—CCL5—atopic dermatitis	7.6e-05	0.00164	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	7.57e-05	0.00164	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.38e-05	0.0016	CbGpPWpGaD
Ondansetron—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	7.38e-05	0.0016	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—CXCL8—atopic dermatitis	7.33e-05	0.00158	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	7.27e-05	0.00157	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	7.27e-05	0.00157	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCL17—atopic dermatitis	7.22e-05	0.00156	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	7.13e-05	0.00154	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	7.1e-05	0.00154	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—CCL5—atopic dermatitis	7.07e-05	0.00153	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CCR3—atopic dermatitis	7.04e-05	0.00152	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	6.91e-05	0.00149	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—CCL5—atopic dermatitis	6.91e-05	0.00149	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL22—atopic dermatitis	6.88e-05	0.00149	CbGpPWpGaD
Ondansetron—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	6.85e-05	0.00148	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—CCR5—atopic dermatitis	6.85e-05	0.00148	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CCL27—atopic dermatitis	6.75e-05	0.00146	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CCR3—atopic dermatitis	6.71e-05	0.00145	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.65e-05	0.00144	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	6.63e-05	0.00143	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.59e-05	0.00142	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	6.53e-05	0.00141	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—CXCL10—atopic dermatitis	6.53e-05	0.00141	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.52e-05	0.00141	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—CCR5—atopic dermatitis	6.37e-05	0.00138	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	6.37e-05	0.00138	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—TAC1—atopic dermatitis	6.28e-05	0.00136	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—NPS—atopic dermatitis	6.28e-05	0.00136	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—CCR5—atopic dermatitis	6.22e-05	0.00134	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CXCR3—atopic dermatitis	6.16e-05	0.00133	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL27—atopic dermatitis	6.13e-05	0.00133	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TAC1—atopic dermatitis	5.98e-05	0.00129	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—NPS—atopic dermatitis	5.98e-05	0.00129	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	5.93e-05	0.00128	CbGpPWpGaD
Ondansetron—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	5.91e-05	0.00128	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	5.91e-05	0.00128	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	5.89e-05	0.00127	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.87e-05	0.00127	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CXCR3—atopic dermatitis	5.86e-05	0.00127	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCL11—atopic dermatitis	5.82e-05	0.00126	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	5.76e-05	0.00125	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FCER2—atopic dermatitis	5.74e-05	0.00124	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	5.62e-05	0.00122	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—CCL5—atopic dermatitis	5.62e-05	0.00122	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL5—atopic dermatitis	5.56e-05	0.0012	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL17—atopic dermatitis	5.5e-05	0.00119	CbGpPWpGaD
Ondansetron—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	5.4e-05	0.00117	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	5.35e-05	0.00116	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL22—atopic dermatitis	5.33e-05	0.00115	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	5.29e-05	0.00114	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CCR3—atopic dermatitis	5.22e-05	0.00113	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	5.14e-05	0.00111	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	5.13e-05	0.00111	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.07e-05	0.0011	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—CCR5—atopic dermatitis	5.06e-05	0.00109	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	5.06e-05	0.00109	CbGpPWpGaD
Ondansetron—HTR1B—G alpha (i) signalling events—CXCL8—atopic dermatitis	5.06e-05	0.00109	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CXCL10—atopic dermatitis	4.98e-05	0.00108	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	4.96e-05	0.00107	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	4.79e-05	0.00103	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL27—atopic dermatitis	4.75e-05	0.00103	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCR3—atopic dermatitis	4.74e-05	0.00103	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CXCL10—atopic dermatitis	4.74e-05	0.00102	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.71e-05	0.00102	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	4.71e-05	0.00102	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—TAC1—atopic dermatitis	4.66e-05	0.00101	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—NPS—atopic dermatitis	4.66e-05	0.00101	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	4.61e-05	0.000996	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	4.57e-05	0.000987	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	4.47e-05	0.000966	CbGpPWpGaD
Ondansetron—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.46e-05	0.000965	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL11—atopic dermatitis	4.43e-05	0.000958	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FCER2—atopic dermatitis	4.37e-05	0.000945	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—IL5—atopic dermatitis	4.33e-05	0.000936	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	4.29e-05	0.000927	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	4.29e-05	0.000927	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CCL5—atopic dermatitis	4.28e-05	0.000926	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL17—atopic dermatitis	4.26e-05	0.000922	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—TAC1—atopic dermatitis	4.23e-05	0.000914	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—NPS—atopic dermatitis	4.23e-05	0.000914	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	4.2e-05	0.000907	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	4.19e-05	0.000905	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CXCR3—atopic dermatitis	4.15e-05	0.000896	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—CXCL8—atopic dermatitis	4.14e-05	0.000895	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GLB1—atopic dermatitis	4.12e-05	0.00089	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	4.11e-05	0.000888	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	4.11e-05	0.000888	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CCL5—atopic dermatitis	4.08e-05	0.000882	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	4.06e-05	0.000878	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	4.03e-05	0.000871	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.03e-05	0.00087	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.02e-05	0.000869	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	3.98e-05	0.00086	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—IL2—atopic dermatitis	3.96e-05	0.000856	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ADSL—atopic dermatitis	3.95e-05	0.000853	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	3.93e-05	0.00085	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	3.86e-05	0.000834	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.85e-05	0.000833	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	3.82e-05	0.000826	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	3.8e-05	0.000822	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—NGF—atopic dermatitis	3.78e-05	0.000817	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	3.76e-05	0.000813	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—CXCL8—atopic dermatitis	3.76e-05	0.000813	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	3.73e-05	0.000806	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	3.73e-05	0.000806	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	3.72e-05	0.000804	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.69e-05	0.000798	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CCR5—atopic dermatitis	3.68e-05	0.000794	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	3.66e-05	0.000791	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	3.62e-05	0.000783	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	3.61e-05	0.000781	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL2—atopic dermatitis	3.59e-05	0.000777	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.55e-05	0.000767	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	3.55e-05	0.000767	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	3.55e-05	0.000767	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.48e-05	0.000752	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	3.47e-05	0.00075	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	3.44e-05	0.000743	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	3.44e-05	0.000743	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	3.35e-05	0.000725	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	3.35e-05	0.000724	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	3.3e-05	0.000713	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.26e-05	0.000704	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	3.25e-05	0.000702	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	3.23e-05	0.000699	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	3.22e-05	0.000696	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	3.22e-05	0.000696	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	3.18e-05	0.000687	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	3.16e-05	0.000683	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—NFKBIA—atopic dermatitis	3.12e-05	0.000673	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.06e-05	0.000662	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	3.06e-05	0.000662	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	3.03e-05	0.000656	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	3.03e-05	0.000656	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3e-05	0.000649	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	2.99e-05	0.000647	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GLB1—atopic dermatitis	2.98e-05	0.000645	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GLB1—atopic dermatitis	2.98e-05	0.000643	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	2.96e-05	0.000639	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	2.9e-05	0.000626	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	2.89e-05	0.000624	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	2.86e-05	0.000619	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ADSL—atopic dermatitis	2.86e-05	0.000618	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ADSL—atopic dermatitis	2.85e-05	0.000617	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	2.85e-05	0.000616	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.81e-05	0.000608	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	2.8e-05	0.000606	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	2.8e-05	0.000606	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	2.7e-05	0.000584	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	2.62e-05	0.000566	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	2.62e-05	0.000566	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	2.6e-05	0.000562	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	2.55e-05	0.000552	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	2.55e-05	0.00055	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	2.53e-05	0.000546	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	2.5e-05	0.00054	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NPS—atopic dermatitis	2.5e-05	0.00054	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	2.47e-05	0.000535	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	2.46e-05	0.000532	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	2.45e-05	0.000529	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	2.42e-05	0.000523	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	2.33e-05	0.000504	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL5—atopic dermatitis	2.32e-05	0.000502	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	2.29e-05	0.000496	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CXCL8—atopic dermatitis	2.22e-05	0.00048	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	2.2e-05	0.000476	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NPS—atopic dermatitis	2.2e-05	0.000476	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	2.2e-05	0.000475	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	2.18e-05	0.000471	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	2.16e-05	0.000467	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	2.13e-05	0.000461	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL2—atopic dermatitis	2.12e-05	0.000459	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.12e-05	0.000457	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL6—atopic dermatitis	2.11e-05	0.000457	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GLB1—atopic dermatitis	2.1e-05	0.000453	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL5—atopic dermatitis	2.05e-05	0.000443	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADSL—atopic dermatitis	2.03e-05	0.000439	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADSL—atopic dermatitis	2.01e-05	0.000435	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	1.98e-05	0.000428	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	1.98e-05	0.000428	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MAPK8—atopic dermatitis	1.95e-05	0.000422	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	1.9e-05	0.000411	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NPS—atopic dermatitis	1.9e-05	0.000411	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.87e-05	0.000403	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.79e-05	0.000387	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.77e-05	0.000382	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	1.75e-05	0.000378	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.73e-05	0.000374	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.72e-05	0.000372	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	1.7e-05	0.000368	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	1.65e-05	0.000357	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NGF—atopic dermatitis	1.58e-05	0.000341	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.57e-05	0.00034	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	1.54e-05	0.000332	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.53e-05	0.00033	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.53e-05	0.00033	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.51e-05	0.000326	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	1.5e-05	0.000325	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	1.5e-05	0.000325	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.46e-05	0.000315	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NGF—atopic dermatitis	1.39e-05	0.000301	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1.39e-05	0.0003	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.38e-05	0.000299	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	1.36e-05	0.000293	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PPARA—atopic dermatitis	1.34e-05	0.000289	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.33e-05	0.000287	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	1.33e-05	0.000286	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.32e-05	0.000285	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.31e-05	0.000282	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	1.3e-05	0.000281	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	1.3e-05	0.000281	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	1.26e-05	0.000272	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL6—atopic dermatitis	1.25e-05	0.00027	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NGF—atopic dermatitis	1.2e-05	0.00026	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.2e-05	0.000259	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	1.17e-05	0.000253	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.15e-05	0.000248	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	1.14e-05	0.000247	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	9.92e-06	0.000214	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PPARA—atopic dermatitis	9.68e-06	0.000209	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PPARA—atopic dermatitis	9.66e-06	0.000209	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	9.28e-06	0.000201	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL2—atopic dermatitis	8.87e-06	0.000192	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	8.83e-06	0.000191	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	8.19e-06	0.000177	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	8.17e-06	0.000176	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL2—atopic dermatitis	7.83e-06	0.000169	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	7.79e-06	0.000168	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	7.21e-06	0.000156	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	7.07e-06	0.000153	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARA—atopic dermatitis	6.87e-06	0.000148	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARA—atopic dermatitis	6.81e-06	0.000147	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL2—atopic dermatitis	6.76e-06	0.000146	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	6.72e-06	0.000145	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	6.22e-06	0.000134	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARA—atopic dermatitis	5.82e-06	0.000126	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—atopic dermatitis	5.21e-06	0.000113	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—atopic dermatitis	4.6e-06	9.95e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.49e-06	9.71e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—atopic dermatitis	3.97e-06	8.59e-05	CbGpPWpGaD
